To preserve our homelands, defend rights of the Indian Treaties with the United States, speak in a unified voice, offer support to our people, offer a forum in which to consult each other and enlighten each other about our peoples, and to otherwise promote the common welfare of all of the Indian Peoples of Montana, Wyoming and Idaho.
- This event has passed.
Opioid Use Disorder in the Black Community: Expert Panel Discussion
January 1, 1970 @ 12:00 am
Free NAADAC Webinar
Friday, December 11, 2020 @ 12-1:30pm ET (11CT/10MT/9PT)
Watch: On-Demand Recording (coming soon…)
Download: PowerPoint Slides (coming soon…)
CE Credit: Online CE Quiz (coming soon…)
Instructions: Access to Online CE Quiz and Certificate Instructions
Answers: Live Event Q & A (coming soon…)
Description
Racial bias rarely protects communities of color. However, it has been noted that in the early years of the opioid epidemic, African-Americans were prescribed opioids far less often than white Americans. Researchers in the addiction profession have noted for decades that opioids were aggressively marketed in white rural areas, yet in African-American communities, prescriptions for opioids were much lower. What was the basis for this difference in prescription practices? Many scientists believe that racial biases, whether explicit or implicit, can explain the difference in care and the reason that the African-American community had lower mortality rates due to the opioid epidemic than their white counterparts. This panel will discuss some of the related research findings and the implications for BIPOC clients, as well as for our healthcare system.
Learning Objectives
- Summarize the discrepancies in opioid prescription practices between African-American communities and white Americans.
- Describe the racial biases that may explain the differences in opioid prescription practices.
- Explain the implications of racial biases in healthcare on BIPOC, as well as on our healthcare system.
Price
Education is FREE to all professionals
Earn 1.5 Continuing Education Hours (CEs)
The CE certificate for this webinar will be available after the webinar takes place. NAADAC Members will be prompted to register for the CE quiz for free, while non-members will be prompted to pay a $20 processing fee to access the quiz. Upon passing the CE quiz, a CE Certificate will be immediately available to download in your profile. Click here for detailed step-by-step instructions for accessing your CE quiz and CE Certificate.
Click here for a complete list of who accepts NAADAC continuing education hours.
Presenters
Sherrá Watkins, PhD, LCMHC-S, LCAS, CRC, CCS, BC-TMH, is the Director of Wellness Counseling and Assistant Professor in the Department of Behavioral Sciences at American University of the Caribbean School of Medicine. She is a leader in transforming organizational systems to increase access and utilization of counseling and coaching services that are diverse and culturally responsive. Her research focuses on decreasing the stigma of mental health and substance use disorders, chronic pain and chronic diseases among BIPOC, and the intersection of racism, racial bias, chronic pain, mental health, and substance use treatment. Watkins is the co-owner of Sister WELLS, Counseling, Coaching & Consulting, PLLC (2017) with Dr. Charla Blumell and Dr. Shawnte’ Elbert. She currently resides in Saint Maarten with her husband and two boys.
Andrew Kolodny, MD, is the Senior Scientist at the Institute for Behavioral Health at the Heller School at Brandeis University and Medical Director of the Opioid Policy Research Collaborative. Kolodny is one of the nation’s leading experts on the prescription opioid and heroin crisis. His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the Executive Director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics. Kolodny previously served as Chief Medical Officer for Phoenix House, a national nonprofit addiction treatment agency and Chair of Psychiatry at Maimonides Medical Center in New York City.
Lamiaa Tolba, PA-C, DMSc, MPAS, joined Novant Cancer Institute – Hematology in April 2018 as a Certified Physician Assistant (PA-C). As a part of the Novant Cancer Institute – Hematology Team, Tolba is collaborating with Blume Pediatric Hematology Oncology Team to establish a transition program for patients with chronic non-malignant hematology condition. Tolba is an Adjunct Professor at Wingate University PA program teaching hematology to PA students. Prior to joining Novant, she worked with the sickle cell team at Levine Cancer Institute where she led and/or collaborated on a number of projects such as the Pain Action Plan and outlining the framework for the Sickle Cell Advanced Clinical Practitioner (ACP) Fellowship for the Center of Advanced Practitioners (CAP). Tolba completed her Doctorate of Medical Science (DMSc) degree from the University of Lynchburg (2019).
Who Should Attend
Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists, and other helping professionals that are interested in learning about addiction-related matters.
Questions or comments about NAADAC Education? Take a look at our Webinar FAQs or email NAADAC.
This presentation is for individual use only and may not be reproduced without permission from NAADAC.